Advertisement

Reactions Weekly

, Volume 1739, Issue 1, pp 201–201 | Cite as

Palbociclib

Febrile neutropenia: case report
Case report
  • 8 Downloads

Reference

  1. Dominick A, et al. Safety of limited dose modifications for palbociclib associated neutropenia in ER+ metastatic breast cancer. Journal of Clinical Oncology 36 (Suppl. 1): no pagination abstr. e13033, No. 15, May 2018. Available from: URL: http://doi.org/10.1200/JCO.2018.36.15_suppl.e13033 [abstract] - USA

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations